European subsidiary to acquire 100% of Bilex SRL, owner of its Belgium plant
3B BlackBio Dx's European subsidiary Coris Bioconcept SRL has entered into a definitive agreement to acquire 100% of Bilex SRL, the owner of the land and building housing Coris's office and manufacturing plant in Gembloux, Belgium.
By ScoutQuest · · 2 min read
- Cash consideration for 100% of Bilex SRL
- €274,817
- Unsecured loan repaid to shareholders
- €1.32 Million
- Expected net annual savings
- €140,000 before depreciation
What is being acquired
Coris Bioconcept SRL, the Belgium-based subsidiary of 3B BlackBio Dx Ltd., has entered into a definitive agreement to acquire 100% of Bilex SRL. Bilex owns the land and building in which Coris's office and manufacturing plant operates at Gembloux, Belgium.
- Sellers: Mr. Thierry Leclipteux (50%) and Mr. Joseph Bertinetti (50%)
- Completion date stated: 18/11/2026
- No governmental or regulatory approvals required
- Not a related party transaction; the promoter and promoter group have no interest in the entity being acquired
What Coris pays
- €274,817 cash consideration for 100% of the shares of Bilex SRL
- Payment of an unsecured loan of €1.32 Million to the two shareholders
- Bilex's long-term building loans of €2.11 Million continue, at an average interest rate of 1.3 %, payable over the remaining 12 years
Stated impact of the acquisition
- Coris moves from tenant to owner-occupier of the facility
- Intercompany rental payments get eliminated on consolidation
- Immediate net annual savings of €140,000 before depreciation
- Going forward, the only property-related expense reflected on the consolidated financial statements will be the direct bank interest paid on Bilex's long-term loans, apart from depreciation
About the property
The building was built in 2023 on a 6,443 m2 land parcel in the Créalys Science Park, Gembloux, and has a surface area of 2,000 m² bringing together administrative offices and laboratories. It is equipped with 256 solar panels and two 20,000-litre rainwater-collection tanks.
Bilex's own numbers (rental income)
- FY2023: €203,500.00
- FY2024: €227,319.00
- FY2025: €232,267.05
What management said
Coris CEO Sébastien Goenen said the shift from tenant to owner-occupier secures long-term control over core operating infrastructure and delivers immediate, recurring savings to the cost base. 3B BlackBio founder CEO Dhirendra Dubey said the acquisition strengthens the operational foundation of Coris, the company's European subsidiary, optimises its rental outflows and is expected to provide long-term certainty over a critical operating asset.
Points to keep in view
The €140,000 saving is stated as a net annual figure before depreciation, and interest on the retained building loans of €2.11 Million continues to be an expense in the consolidated accounts. The consideration, the loan repayment and the retained debt are all denominated in euros, so they sit at the subsidiary level in Belgium.
Also from 3B BlackBio Dx
3B BlackBio Dx reiterates Q2-FY27 investor presentation in one-on-one meet with Fortuna Asset Managers on 21 Nov 2026
21 Nov 2026
3B BlackBio Dx corrects Clockvine Capital investor meet time to 16:00 hrs IST from 04:00 hrs
19 Nov 2026
3B BlackBio Dx schedules one-on-one virtual investor meet with Clockvine Capital Advisors on 24 Nov 2026
19 Nov 2026
More numbers
- Cash consideration for 100% of Bilex SRL€274,817
- Unsecured loan paid to two shareholders€1.32 Million
- Bilex long-term building loans continued€2.11 Million
- Average interest rate on building loans1.3 %
- Stated net annual savings before depreciation€140,000
- Bilex rental income FY2025€232,267.05
- Equity shareholding acquired in Bilex SRL100%
- Remaining repayment period on building loans12 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.